Hjem › Interstitielle lungesykdommer
Kliniske studier for Interstitielle lungesykdommer rekrutterer i USA
53 studier for Interstitielle lungesykdommer rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- New York City, NY18 studier
- Philadelphia, PA16 studier
- Los Angeles, CA14 studier
- Kansas City, KS13 studier
- Durham, NC13 studier
- Charleston, SC13 studier
- Chicago, IL12 studier
- Houston, TX12 studier
- Aurora, CO11 studier
- Ann Arbor, MI11 studier
- Phoenix, AZ9 studier
- Salt Lake City, UT9 studier
- Boston, MA9 studier
- Rochester, MN9 studier
- Dallas, TX9 studier
- Birmingham, AL9 studier
- Orlando, FL9 studier
- Tampa, FL8 studier
- Cincinnati, OH8 studier
- Minneapolis, MN8 studier
- Bend, OR7 studier
- San Francisco, CA7 studier
- Richmond, VA6 studier
- Washington, DC6 studier
- Denver, CO6 studier
- Indianapolis, IN6 studier
- Gainesville, FL5 studier
- Naples, FL5 studier
- Jacksonville, FL5 studier
- Columbus, OH5 studier
- Oklahoma City, OK5 studier
- Winston-Salem, NC5 studier
- Cleveland, OH5 studier
- Albuquerque, NM5 studier
- Nashville, TN5 studier
- Pittsburgh, PA5 studier
- Scottsdale, AZ4 studier
- New Haven, CT4 studier
- Rochester, NY4 studier
- Greensboro, NC4 studier
Etter delstat
- Alabama9 studier
- Arizona13 studier
- California22 studier
- Colorado15 studier
- Connecticut4 studier
- District of Columbia5 studier
- Florida24 studier
- Georgia3 studier
- Illinois12 studier
- Indiana6 studier
- Kansas13 studier
- Kentucky4 studier
- Louisiana5 studier
- Maryland5 studier
- Massachusetts11 studier
- Michigan16 studier
- Minnesota14 studier
- Mississippi3 studier
- Missouri6 studier
- Nevada4 studier
- New Jersey3 studier
- New Mexico5 studier
- New York20 studier
- North Carolina18 studier
- Ohio14 studier
- Oklahoma5 studier
- Oregon9 studier
- Pennsylvania18 studier
- South Carolina14 studier
- Tennessee7 studier
- Texas18 studier
- Utah9 studier
- Virginia8 studier
- Wisconsin4 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
RekruttererFase 3
Alder 40 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT05798923Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
RekruttererFase 3
Alder 18 til 100 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07613099Pulmonary Fibrosis Foundation Community Registry
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT05382572A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07323732A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07816185SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07269262A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06572384Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07473700A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RekruttererFase 2
Alder 18 til 85 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07333183Dorothy P. and Richard P. Simmons Center for ILD Research Registry
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT00258583DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 26. aug. 2026 · NCT06388421Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT07486869PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
RekruttererObservasjonsstudie
Alder 18 til 80 · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06855329Platform Clinical Study for Conquering Scleroderma
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RekruttererFase 2/3
Alder 18 til 75 · Alle kjønn · Oppdatert 17. aug. 2026 · NCT06328777Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
RekruttererFase 2
Alder 8 til 60 · Alle kjønn · Oppdatert 14. aug. 2026 · NCT03630211An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 13. aug. 2026 · NCT07234032Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.